Related Experiment Video
Updated: Sep 11, 2025

A High-Fidelity Porcine Model of Orthotopic Heart Transplantation Following Donation after Circulatory Death
Published on: June 6, 2025
Evolving Changes in Centre-Level Utilization of Longer Distance Donors in Heart Transplantation
Krishna Bhandari1, Khaled Shorbaji1, Akinwale Victor Famotire1
1Division of Cardiothoracic Surgery, Medical University of South Carolina, Charleston, SC 29425, United States.
Insights
The use of longer distance donors (LDD) in heart transplantation (HT) significantly increased after the 2018 policy change. Survival outcomes for HT recipients using LDD are notably better than with non-LDD, challenging previous assumptions about donor distance and ischemia time.
Area of Science:
- Cardiology
- Transplantation Medicine
- Public Health Policy
Background:
- The 2018 allocation policy change aimed to optimize organ utilization in heart transplantation (HT).
- Understanding the impact of increased donor travel distances on HT outcomes is crucial.
Purpose of the Study:
- To evaluate changes in the utilization of longer distance donors (LDD) for HT before and after the 2018 policy change.
- To assess the impact of LDD use on patient survival post-heart transplantation.
Main Methods:
- Analysis of adult HT recipients (2010-2023) from the United Network for Organ Sharing registry.
- Trend analysis using the Mann-Kendall test and propensity-matched survival analyses (Kaplan-Meier, restricted mean survival time, Cox models).
- Comparison of outcomes between LDD and non-LDD recipients, considering donor distance and cold ischemia time.
Main Results:
- A significant increase in LDD utilization post-2018 policy change, with mean donor distance rising from 171 to 288 miles.
- Risk-adjusted survival was significantly better for LDD recipients compared to non-LDD recipients at 30-day, 1-year, and 5-year follow-ups.
- A weak correlation was observed between donor distance and ischemia time in the matched cohort, suggesting distance is not a direct surrogate for ischemia.
Conclusions:
- The 2018 policy change led to a substantial increase in the use of LDD in heart transplantation.
- Longer donor distance does not equate to longer ischemia time, and LDD use is associated with improved survival outcomes.
- Further research is warranted to fully elucidate the benefits and implications of LDD in HT.
Objectives:
This study evaluates changes in centre-level utilization of longer distance donors (LDD) in heart transplantation (HT) before and after the allocation policy change in 2018.
Methods:
Adult HT recipients from 2010 to 2023 were identified from the United Network for Organ Sharing registry. Patients were categorized based on donor centre distance and policy change. The Mann-Kendall trend test was utilized for trend analysis. A propensity-matched analysis was performed. Survival analyses were performed using Kaplan-Meier, restricted mean survival time, and multivariable Cox proportional models. Interaction analysis with Bonferroni correction and sensitivity analysis to test the robustness of primary findings were performed.
Results:
Among 32 036 recipients from 152 centres, 29 410 from ≤500 miles and 2626 from >500 miles. The mean distance increased from 171 miles to 288 (P < .001) and mean cold ischaemia time from 3.20 to 3.60 h (P < .001) after allocation change. The proportion of recipients with LDD increased from 5.50% in 2010 to 14.00% in 2022, P = .021. In the unmatched cohort, unadjusted 30-day, 1-year, and 5-year survival was comparable between LDD and non-LDD recipients (P > .05). However, risk-adjusted survival in the matched cohort was significantly better with LDD: 30-day (0.60, 0.43-0.82, P = .002), 1-year (0.67, 0.55-0.82, P < .001), and 5-y (0.75, 0.65-0.86, P < .001). Similar findings persisted even after restricted mean survival time analysis. There was a weak correlation between distance and ischaemia time in the matched cohort (r = 0.19).
Conclusions:
There has been a substantial increase in the use of LDD following the allocation change. Distance is not a surrogate for ischaemia time. Survival after HT with LDD use is significantly better compared to non-LDD, but further research is warranted.
More Related Videos
08:49Author Spotlight: Enhancing Graft Viability Assessment Through Quantitative Metrics and Innovative Reservoir Systems
Published on: August 2, 2024
09:54Lung Rapid Recovery Procurement Combined with Abdominal Normothermic Regional Perfusion in Controlled Donation after Circulatory Death
Published on: August 15, 2022
Related Concept Videos
Kidney Transplant I: Introduction
Tissue Transplantation
The Biology of Tissue Transplantation
The biology of tissue transplantation hinges on the Major Histocompatibility Complex (MHC) molecules. These molecules...
Bone Marrow Sampling and Transplants
The transplant begins with high doses of chemotherapy and radiation treatment, which aim to destroy...